Evidence map›Paper›PMID 40597293›Full record

ArticleFEBS letters2025

Intron-oriented HTLV-1 integration in an adult T-cell leukemia/lymphoma cell line sustains expression of intact ift81 mRNA.

Mayuko Yagi, Yuka Hirosawa, Yusaku Sagisaka, Minami Hama, Satoshi Takeda, Jun A Komano

Abstract read
In one paragraph

Article in FEBS letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mayuko YagiFaculty of Pharmacy, Department of Microbiology and Infection Control, Osaka Medical and Pharmaceutical University, Japan.
Yuka HirosawaFaculty of Pharmacy, Department of Microbiology and Infection Control, Osaka Medical and Pharmaceutical University, Japan.
Yusaku SagisakaFaculty of Pharmacy, Department of Microbiology and Infection Control, Osaka Medical and Pharmaceutical University, Japan.
Minami HamaFaculty of Pharmacy, Department of Microbiology and Infection Control, Osaka Medical and Pharmaceutical University, Japan.
Satoshi TakedaLaboratory Animal and Pathogen Bank, Research Center for Biosafety, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Jun A KomanoFaculty of Pharmacy, Department of Microbiology and Infection Control, Osaka Medical and Pharmaceutical University, Japan.ORCID https://orcid.org/0009-0000-1204-3938

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The oncogene hbz in human T-cell leukemia virus type 1 (HTLV-1) is encoded on the antisense strand, generating spliced and unspliced transcripts. We investigated splicing regulation in the context of cellular splice donors and the hbz splice acceptor when integrated within the host chromosomal DNA. In ATL cell line ED, the HTLV-1 provirus integrated into the 10th intron of the gene ift81, aligning transcriptionally with ift81. Both genes were actively transcribed, yielding ift81-hbz chimeric mRNA but not hbz-ift81. Splicing efficiency from the 10th exon of ift81 to the 2nd exon of hbz was 24.2% at most, suggesting reduced function of hbz splice signals on ift81-driven transcripts. This stochastic regulation may minimize disruption of cellular gene expression by proviral integration, potentially promoting survival of HTLV-1-infected cells and contributing to HTLV-1 pathogenesis.

Indexed as

DNA-Binding ProteinsHuman T-lymphotropic virus 1IntronsLeukemia-Lymphoma, Adult T-CellRNA, MessengerTranscription FactorsVirus IntegrationBasic-Leucine Zipper Transcription FactorsCell Line, TumorHumansProvirusesRetroviridae ProteinsRNA SplicingBasic-Leucine Zipper Transcription FactorsDNA-Binding ProteinsHBZ protein, human T-cell leukemia virus type IRetroviridae ProteinsRNA, MessengerTranscription FactorsATLchimeric transcriptcis‐acting elementHTLV‐1integration

Identifiers

PMID40597293
PMCPMC12457699

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.